Government Permit Issues in Healthcare M&A Transactions: Buyer and Seller Strategies, Compliance Challenges
Mitigating Client Risk When Structuring Executory Periods, Reps and Warranties, Process Extensions, Breakup Fees, and More
A live 90-minute CLE video webinar with interactive Q&A
This CLE webinar will guide healthcare counsel through government permit issues that may occur in healthcare transactions when buyers must work with requisite agencies to transfer the seller's permits required for business operations. The panel will examine how to mitigate the risk of those issues—whether representing buyers or sellers—by establishing sufficient executory periods, creating representations, warranties, and covenants that best protect their clients, providing for potential process extensions and breakup fees, and other important considerations necessary for structuring the deal.
Outline
- Introduction: government permits in healthcare transactions
- Executory periods
- Buyer considerations
- Seller considerations
- Representations, warranties, and covenants
- Buyer considerations
- Seller considerations
- Process extensions, liquidated damages
- Buyer considerations
- Seller considerations
- Practitioner takeaways and best practices
Benefits
The panel will review these and other key issues:
- What is the importance of having a sufficiently long executory period in a healthcare transaction when transferring government permits? How may determining sufficiency vary depending on whether counsel represents the buyer or the seller?
- What representations, warranties, and covenants related to government permits may the buyer want from the seller? The seller from the buyer?
- What are considerations when negotiating potential process extensions or breakup fees in the event the buyer fails to transfer the necessary permits within the prescribed period?
Faculty

Evelynn A. Bui
Attorney
Venable
Ms. Bui focuses her practice on matters related to corporate law and technology, media, and commercial transactions... | Read More
Ms. Bui focuses her practice on matters related to corporate law and technology, media, and commercial transactions involving intellectual property (IP) licensing, marketing and distribution, endorsements, and consulting services for clients in the life sciences, technology, and media and entertainment industries. She also has experience representing healthcare industry clients in mergers and acquisitions (M&A), governance, structuring of professional practice and related management businesses, and regulatory matters related to corporate practice prohibitions and other regulatory issues affecting transactions.
Close
Ari J. Markenson
Partner
Venable
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients,... | Read More
Mr. Markenson practices at the intersection of healthcare, law, and business. He advises healthcare industry clients, including investors, lenders, providers, and suppliers, on a broad range of regulatory and corporate matters, and has significant experience conducting due diligence in complex healthcare industry acquisitions and financial transactions. He regularly represents private equity firms and lenders in such transactions and evaluates and advises on compliance and regulatory issues with regard to sellers and potential borrowers from banks and financing sources. He also advises various healthcare entities on regulatory matters, including conditions for participation, fraud and abuse, and survey, certification, licensure, and enforcement issues, Medicare and Medicaid conditions for participation, obtaining a certificate of need approval, and state licensure.
CloseEarly Discount (through 09/26/25)